-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

Credit Suisse Lowers Olema Pharmaceuticals' Price Target to $11 From $12, Keeps Outperform Rating

Credit Suisse Lowers Olema Pharmaceuticals' Price Target to $11 From $12, Keeps Outperform Rating

MT Newswires · 03/10/2023 04:15